FCGR2B and neoplasm: We observed similar phenotype that the anti-tumor activity of LOB12.3-mIgG1 is significantly reduced in Fcgr2b−/−, while 3H3-mIgG1 showed a weak but significant anti-tumor activity in Fcgr2b−/− mice (Fig. 3c).